Intercept Pharmaceuticals Announces Full Exercise of Underwriters' Option to …
Intercept Pharmaceuticals Announces Full Exercise of Underwriters' Option to Purchase Additional Shares. NEW YORK, Oct. 15, 2012 (GLOBE NEWSWIRE) — Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a clinical stage biopharmaceutical company …
See all stories on this topic »